The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Cisplatin, Doxorubicin, and Delayed Surgery for Childhood Hepatoblastoma: A Successful Approach—Results of the First Prospective Study of the International Society of Pediatric Oncology
Abstract
PURPOSE: Hepatoblastoma (HB) is a rare malignant liver tumor which occurs almost exclusively in childhood. In the 1970s, survival was approximately 20% to 30%. Since the introduction of cisplatin (PLA) and doxorubicin (DO) into the chemotherapy regimens used to treat these patients, the survival rate has improved dramatically. In most recent studies, primary surgery preceded chemotherapy. In this study by the liver group of the International Society of Pediatric Oncology the aim was to improve survival and reduce operative morbidity and mortality by using preoperative chemotherapy. PATIENTS AND METHODS: After biopsy and assessment of pretreatment extent of disease all patients were treated with continuous 24-hour intravenous infusion of PLA 80 mg/m 2 followed by DO 60 mg/m 2 over 48 hours (PLADO). After four courses of this chemotherapy, patients were reassessed. Where possible, the primary tumor was resected and treatment completed with two more courses of chemotherapy. RESULTS: One hundred fifty-four patients were registered in the study, and 138 received preoperative chemotherapy. One hundred thirteen (82%) showed a partial response with tumor shrinkage and serial decrease of serum alpha-fetoprotein levels. One hundred fifteen patients had delayed surgery, and 106 (including six with liver transplants) had complete resection of primary tumor. Five-year event-free survival was 66%, and overall survival was 75%. CONCLUSION: This study demonstrates that international collaboration on a large scale is feasible. The toxicity of chemotherapy and morbidity of surgery were acceptable and the overall survival gratifyingly high. We now regard PLADO chemotherapy and delayed surgery to be the best available treatment for children with HB. Other treatment programs should be measured against this standard.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
The international incidence of childhood cancer
Parkin, D. M., Stiller, C. A., Draper, G. J., & Bieber, C. A. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420408 · Cited by 1,022
Hepatoblastoma and hepatocarcinoma in infancy and childhood.Report of 47 cases
Ishak, K. G., & Glunz, P. R. (1967) · Cancer · doi:10.1002/1097-0142(1967)20:3<396::aid-cncr2820200308>3.0.co;2-o · Cited by 424
Serum Alpha Fetoprotein (AFP) Levels in Normal Infants
Wu, J. T., Book, L., & Sudar, K. (1981) · Pediatric Research · doi:10.1203/00006450-198101000-00012 · Cited by 320
Association between hepatoblastoma and polyposis coli.
Kingston, J. E., Herbert, A. S., Draper, G. J., & Mann, J. R. (1983) · Archives of Disease in Childhood · doi:10.1136/adc.58.12.959 · Cited by 115
Partial reversibility of cisplatin nephrotoxicity in children
Brock, P. R., Koliouskas, D. E., Barratt, T. M., Yeomans, E. C., & Pritchard, J. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83372-4 · Cited by 111
Self-citationChemotherapy Effects on Hepatoblastoma: A Histological Study
Saxena, R., Salisbury, J. R., Davenport, M., Howard, E. R., Mowat, A. P., Mieli‐Vergani, G., Leake, J. L., Malone, M., Pritchard, J., Spitz, L., et al. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199312000-00008 · Cited by 74
Self-citationOrthotopic liver transplantation for unresectable hepatoblastoma: A single center's experience
Al-Oabandi, W., Jenkinson, H. C., BUCKELS, J. A. C., Mayer, A. D., McKiernan, P. J., Morland, B. J., John, P., & Kelly, D. A. (1999) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(99)90164-1 · Cited by 63
Cited by
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Li, Y., Womer, R. B., & Silber, J. H. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.009 · Cited by 358
Zsiros, J., Brugieres, L., Brock, P., Roebuck, D., Maibach, R., Zimmermann, A., Childs, M., Pariente, D., Laithier, V., Otte, J.-B., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70272-9 · Cited by 345
Self-citationHepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy
Czauderna, P., Lopez-Terrada, D., Hiyama, E., Häberle, B., Malogolowkin, M. H., & Meyers, R. L. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000046 · Cited by 306
Renard, C.-A., Labalette, C., Armengol, C., Cougot, D., Wei, Y., Cairo, S., Pineau, P., Neuveut, C., de Reyniès, A., Dejean, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2344 · Cited by 157
Metadata
- Authors
- Pritchard, J., Brown, J., Shafford, E., Perilongo, G., Brock, P., Dicks-Mireaux, C., Keeling, J., Phillips, A., Vos, A., & Plaschkes, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 3819-3828
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1917601863
- Cited by
- 269
- References
- 10
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cisplatin, Doxorubicin, and Delayed Surgery for Childhood Hepatoblastoma: A Successful Approach—Results of the First Prospective Study of the International Society of Pediatric Oncology. https://app.cochat.ai/papers/10.1200/jco.2000.18.22.3819
- The paper
- Pritchard, J., Brown, J., Shafford, E., Perilongo, G., Brock, P., Dicks-Mireaux, C., Keeling, J., Phillips, A., Vos, A., & Plaschkes, J. (2000). Cisplatin, Doxorubicin, and Delayed Surgery for Childhood Hepatoblastoma: A Successful Approach—Results of the First Prospective Study of the International Society of Pediatric Oncology. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2000.18.22.3819
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
